Get our E-Alerts
Articles ▼ All Issues About Us ▼ Submit Manuscript Get our E-Alerts
Review Article
06 Aug 2025
Beyond the Prescription Pad: A Guide to Over-the-Counter Itch Management
Duncan MacIntyre, BS, Peter Lio, MD
Review Article
15 Jan 2026
Beyond the Prescription Pad: A Guide to Over-the-Counter Itch Management
Duncan MacIntyre, BS, Peter Lio, MD
DOI:
10.64550/0sjtt120
Reviewed by:
Apple Bodemer, MD, Jacquelyn Dosal, MD
Abstract

Itch is a common and often distressing symptom that significantly impacts quality of life. While identifying and treating the underlying cause is ideal, this is not always immediately possible. Fortunately, there are many effective therapies for managing itch, but they may not be accessible or suitable for every patient. In the meantime, over-the-counter (OTC) treatments and techniques remain essential for many and are often used in conjunction with prescription therapies. This review focuses on accessible OTC options to help manage itch.

Introduction

Pruritus, commonly known as itch, is a common and often distressing symptom that can profoundly affect various aspects of an individual’s life. Pruritus is categorized into acute and chronic forms, which can significantly impact daily functioning, emotional well-being, and sleep quality.1 Chronic pruritus, characterized by itch symptoms persisting over six weeks, affects up to 22% of people at some point in their lives and is the chief concern for approximately 1% of hospital visits in the United States annually.2,3

When addressing itch, it is essential first to identify and treat any underlying causes, whether infectious, inflammatory, or otherwise, as this approach is ideal for achieving symptom resolution. Pruritus has many causes, ranging from skin-related conditions to systemic diseases, making it a complex symptom to manage. Although powerful new therapies have revolutionized itch management, over-the-counter (OTC) treatments and techniques remain essential for many and are often used with powerful prescription therapies. This review will focus more broadly on accessible OTC therapies to manage itch.

Topical Corticosteroids

Topical corticosteroids (TCS) are a cornerstone treatment for inflammatory skin conditions and are often used to alleviate pruritus by reducing inflammation, vasodilation, and immune cell infiltration in the skin.4 TCS vary widely in potency, ranging from lower-strength OTC options to more potent formulations requiring a prescription for more severe cases. OTC hydrocortisone is available in 0.5% and 1% formulations and is commonly used to relieve itching associated with minor skin irritations, insect bites, eczema, and allergic reactions.5 While generally considered safe, topical use of OTC hydrocortisone has been associated with cutaneous side effects, particularly on the face and folds, and younger children may be more susceptible to these effects.5,6 Long-term continuous use of topical corticosteroids, even low-potency ones, is not recommended. Moreover, while low-potency formulations can give itch relief for some, many patients find them only modestly effective at best and generally ineffective when used outside of underlying inflammatory conditions. Table 1 summarizes some of the most commonly available OTC topical corticosteroids.

322238 Select OTC topical corticosteroids.

Generic Name Example Brand Name(s) Mechanism of Action
Hydrocortisone 0.5% Cortaid®, Cortizone-10®, Aveeno® Anti-Itch Reduces inflammation, vasodilation, and immune cell infiltration in the skin by suppressing the release of pro-inflammatory mediators.
Hydrocortisone 1% Cortaid® Maximum Strength, Cortizone-10® Maximum Strength, CeraVe® 1%Hydrocortisone Anti-Itch Cream

Antihistamines

Histamine, a key driver of itch, is released during various skin reactions and contributes to the discomfort associated with conditions like chronic pruritus, allergies, and insect bites, making antihistamines excellent OTC options for relieving pruritus.7 Antihistamines are available in both topical and oral forms. Diphenhydramine, the most widely available OTC first-generation antihistamine, is the only antihistamine available topically to treat itch, with its antipruritic effects supported by controlled studies.8 However, topical diphenhydramine should not be used on large body areas, as it may cause skin irritation, photosensitivity, and rash.9 Although severe complications are very rare, topical diphenhydramine has caused severe toxicity in infants, as illustrated by a 2½-year-old who developed severe CNS effects after calamine-diphenhydramine lotion was applied during a varicella rash.10 Although extremely uncommon, fatal outcomes have been reported, including a 3-year-old who died after diphenhydramine cream was repeatedly applied, resulting in lethal systemic absorption.11 Topical antihistamines are discouraged explicitly in the American Academy of Dermatology guidelines for atopic dermatitis (AD), as they are known to be frequent sensitizers.12

Oral antihistamines are widely used to manage chronic itch from dermatological and non-dermatological conditions.13 Both first and second-generation antihistamines are viable options for treating pruritus OTC by targeting the same receptor. However, first-generation antihistamines cross the blood-brain barrier, leading to sedative effects. In contrast, second-generation antihistamines offer longer-lasting relief with less sedation.13 First-generation antihistamines like diphenhydramine have been proven more effective for managing chronic itch.14 Despite their sedative side effects due to crossing the blood-brain barrier, they may also mimic the relief of scratching by calming the brain areas responsible for itch perception.15

However, antihistamines present unique challenges when managing pruritus. While antihistamines are used as adjunctive treatments in certain chronic skin conditions, their effectiveness for treating itch associated with some conditions remains uncertain. Despite their widespread use in atopic dermatitis, few high-quality studies have demonstrated that antihistamines, particularly expensive non-sedating agents, provide significant relief from itch.16 Even sedating antihistamines, while sometimes beneficial for temporarily improving sleep, do not directly control AD symptoms or reduce itch meaningfully.17 This highlights the need for patients with chronic skin conditions to be cautious when considering antihistamines as a primary treatment for itch. Instead, they should discuss their symptoms with a healthcare practitioner to explore therapies that may offer greater long-term relief. Some widely used OTC antihistamines for itch relief are outlined in Table 2.

322239 Select OTC antihistamines.

Generic Name Form Example Brand Name(s) Mechanism of Action
Diphenhydramine Topical, Oral Benadryl® Blocks H1 histamine receptors to alleviate itch and allergic responses, sedative effects in oral form occur due to blood-brain barrier penetration.
Chlorpheniramine Oral Chlor-Trimeton®
Loratadine Oral Claritin®, Alavert® Blocks H1 histamine receptors, providing long-lasting relief from allergic symptoms with minimal sedation.
Cetirizine Oral Zyrtec®
Fexofenadine Oral Allegra®

Topical Anesthetics

Topical anesthetics, such as lidocaine, pramoxine, and benzocaine, are practical options for temporarily managing localized itch, particularly in neuropathic, facial, or anogenital pruritus cases.13 Lidocaine is available OTC in concentrations ranging from 2-10% in gels, solutions, ointments, and sprays that typically act within 1-2 minutes, reach peak efficacy at 5 minutes, and last about 15 minutes.18 Pramoxine is available in 1%-2% concentrations as creams, lotions, or gels, providing rapid relief from itch within 30 minutes by interfering with sensory nerve transmission.19,20

Benzocaine is available in 6-20% concentrations as sprays, gels, gel patches, ointments, or solutions, with 20% formulations providing anesthesia within 30 seconds and lasting approximately 5 to 15 minutes after reaching full effect in 2 to 3 minutes.18 Topical anesthetics provide effective relief for itch. However, they may carry risks such as systemic toxicity, including methemoglobinemia and central nervous system, or cardiac side effects, especially when applied to large areas, damaged skin, or used for extended periods.21,22 Therefore, their use requires careful consideration of the anatomic location, surface area treated, and duration of application.13,21 Some of the most popular OTC topical anesthetics can be found in Table 3.

322240 Select OTC topical anesthetics.

Generic Name Example Brand Name(s) Mechanism of Action
Lidocaine Aspercreme®, Lidoderm®, Salonpas® Blocks sodium channels in nerve endings, preventing sensory nerve transmission and providing localized anesthesia.
Pramoxine Sarna Sensitive®, Proctofoam®, Gold Bond® Dual Action Anti-Itch Cream, CeraVe® Itch Relief Moisturizing Lotion Interferes with sensory nerve transmission, offering rapid relief from localized itch and irritation.
Benzocaine Orajel®, Anbesol®, Americaine® Blocks nerve signal transmission by stabilizing neuronal membranes, providing rapid and temporary anesthesia.

Cooling Agents

Menthol is a natural compound used in dermatology for its antipruritic properties, providing a cooling sensation that helps alleviate itch.23 At OTC concentrations up to 16%, menthol works by depressing sensory receptors at lower levels and stimulating them at higher levels, effectively acting as a counter-irritant to reduce itch.24 Menthol’s cooling effect is most effective in low concentrations between 1-5%, and higher levels can sometimes lead to irritation, highlighting the importance of careful dosing for optimal relief.25

Camphor, long used as an antipruritic, is often combined with other topical and systemic treatments despite limited research on its efficacy.13,26 It is theorized that camphor creates its cooling sensation by stimulating nerve endings sensitive to cold and warmth by activating involved sensory pathways, which helps to relieve pain, itch, and irritation.27 OTC camphor products are currently limited to a maximum concentration of 11%.28

In addition to ingredients like menthol and camphor, direct skin cooling can also relieve itch. These include tools like metal roller-ball applicators, ice packs, and certain OTC products that create immediate skin cooling upon contact. Physical cooling can reduce skin temperature and temporarily interrupt itch signaling by decreasing the excitability of cutaneous nerve fibers.29 Table 4 highlights some of the most frequently used OTC cooling agents for itch relief.

322241 Select OTC topical cooling agents

Generic Name Example Brand Name(s) Mechanism of Action
Menthol Sarna®, Icy Hot®, Biofreeze®, Gold Bond® Provides a cooling sensation by depressing sensory receptors at lower concentrations and stimulating them at higher concentrations, acting as a counter-irritant to reduce itch.
Camphor Sarna®, Tiger Balm®, Vicks® VapoRub Stimulates nerve endings sensitive to cold and warmth, creating a cooling effect that alleviates pain, itch, and irritation.
Physical Cooling Cetaphil® Itch Relief Gel, Lomalux® Cool It! Ice Roller, Ice Packs Physically cooling the skin can relieve the sensation of itch.

Natural Remedies

Natural remedies can provide effective relief and valuable alternatives or complementary treatments. Many patients with chronic pruritus turn to herbal and natural remedies due to the limitations of conventional treatments, particularly when the cause of the itch is unclear or when standard therapies provide only partial relief.30 Certain treatments work by directly modulating nerve pathways involved in itch perception, while others help restore the skin barrier and reduce inflammation.30–32 Among these, aloe vera and capsaicin are two of the most widely used natural remedies for itch relief due to their distinct mechanisms of action and proven benefits.

Aloe vera is known for its hydrating, anti-inflammatory, and antimicrobial properties and is an effective natural remedy for relieving pruritus and promoting skin healing.33 The polysaccharides contained within aloe vera help soothe inflamed skin, retain moisture, and support the skin barrier.34 Clinical studies have suggested the potential benefit of using aloe vera for pruritus associated with burn injuries and atopic dermatitis, though the overall quality of evidence remains limited.35,36 Aloe vera is generally well tolerated, but rare cases of allergic contact dermatitis have been reported, underscoring the need for caution in sensitive individuals.37

Topical capsaicin, derived from chili peppers, is commonly used as a pain-relieving medication and provides antipruritic effects by targeting pathways involved in the sensation of itch.38 Capsaicin is available OTC in concentrations ranging from 0.025% to 0.1% in cream and patch forms.13 During the initial implementation of capsaicin treatment, many patients commonly experience an initial burning sensation, pain, itch, stinging, and erythema due to neurogenic inflammation, which may impact adherence.13,39

Tea tree oil, derived from Melaleuca alternifolia, has been shown to possess antimicrobial and anti-inflammatory properties, which remain its primary therapeutic uses.40 Despite its popularity, evidence for tea tree oil as an antipruritic is limited, with small studies and case reports suggesting potential benefit in conditions such as dandruff and minor skin irritation.40 However, its use requires caution, as tea tree oil has been associated with allergic contact dermatitis, particularly when applied to areas with a disrupted skin barrier, highlighting the importance of dilution and appropriate formulation.41

Calendula is a botanical preparation derived from Calendula officinalis that has long been recognized for its anti-inflammatory, antimicrobial, and wound-healing properties.42 Although it has been incorporated into topical creams marketed for irritated or itchy skin, evidence supporting its role as an antipruritic remains limited to small trials and traditional use.30,33 Based on current evidence, calendula’s role in itch management remains more a reflection of tradition and consumer preference than of robust clinical evidence.

Beyond these well-established options, other natural remedies have been explored for their potential itch-relieving benefits. While some work through their anti-inflammatory or antimicrobial effects, others help by forming a protective barrier that soothes and restores irritated skin.30 A variety of the most commonly used OTC natural remedies for pruritus are listed in Table 5.

322242 Select OTC natural preparations.

Generic Name Example Brand Name(s) Mechanism of Action
Aloe vera Generic aloe vera gels and creams Hydrates and soothes the skin, reduces inflammation, and promotes wound healing through polysaccharides like acemannan.
Capsaicin Capzasin®, Zostrix® Depletes substance P from sensory nerves, reducing itch transmission and pain signals over time.
Tea tree oil Generic tea tree oil Has antimicrobial and anti-inflammatory properties that may help reduce itch associated with skin irritation and dandruff.
Coconut oil Generic organic coconut oil Moisturizes and helps restore the skin barrier, with anti-inflammatory and antimicrobial effects.
Honey-based ointments Medihoney®, YoRo NaturalsTM Provides antimicrobial and wound-healing benefits while maintaining skin hydration and reducing irritation.
Calendula Boiron® Calendula Cream, generic formulations Has anti-inflammatory, antimicrobial, and skin-soothing properties that help relieve itch and irritation.

Moisturizers, Emollients, and Skin Protectants

Moisturizers, emollients, and skin protectants are crucial in managing itch by maintaining skin hydration, reinforcing the skin barrier, and shielding irritated areas from environmental stressors. Moisturizers primarily function by increasing water content in the skin and preventing transepidermal water loss.43 Emollients work by softening and smoothing the skin, helping to restore flexibility and comfort, particularly in dry or sensitive skin types.44 Skin protectants form a physical barrier over compromised areas, reducing irritation and shielding the skin from further damage.45 Some commonly available OTC moisturizers, emollients, and skin protectants can be found in Table 6. It is important to know that some ingredients have multiple mechanisms of action, and the classification is somewhat arbitrary here.

322243 Select OTC moisturizers, emollients, and skin protectants.

Key ingredient Example Brand Name(s) Mechanism of Action
Colloidal oatmeal Aveeno®, Eucerin®, generic formulations Forms a protective barrier, reduces inflammation, and soothes irritation by binding to skin proteins.
Ceramide-containing creams CeraVe®, Eucerin®, Aveeno® Strengthens the skin barrier and helps retain moisture, reducing dryness and itch.
Shea butter-based creams Raw Shea Butter, Palmer’s®, generic Deeply moisturizes and contains anti-inflammatory properties that help soothe irritated skin.
Cocoa butter-based creams Palmer’s®, Vaseline® Cocoa Butter Hydrates and soothes dry, itchy skin while supporting skin elasticity.
Urea-based creams Eucerin® UreaRepair, generic formulations Exfoliates and hydrates, helping with dry, scaly, and itchy skin conditions.
Glycerin-containing lotions Cetaphil®, Neutrogena®, generic formulations Draws moisture into the skin and helps maintain hydration for itch relief.
Dimethicone Cetaphil®, CeraVe®, generic formulations Forms a barrier on the skin to lock in moisture and protect against irritants.
Mineral oil Johnson’s® Baby Oil, generic formulations Works as an emollient by trapping moisture and softening dry, itchy skin.
Lanolin Lansinoh®, generic formulations Moisturizes and restores the skin barrier, commonly used for chapped or irritated skin.
Zinc oxide Desitin®, Balmex®, generic formulations Acts as a skin protectant and mild astringent, reducing irritation and inflammation.
Calamine Caladryl®, generic formulations Provides a cooling effect and mild astringent action to relieve itch and dry out weeping skin lesions.
Petrolatum Vaseline®, Aquaphor® Creates an occlusive barrier to prevent moisture loss and protect sensitive skin.

Unknown Mechanism

Certain OTC antipruritic treatments do not fit into established pharmacologic classes. These products often contain multiple active ingredients with potential antipruritic properties, making it difficult to attribute their effects to a single mechanism of action. In some cases, the exact way these treatments relieve itch remains unclear.

OTC formulations containing aluminum acetate and strontium, some of which also include ceramides, are widely used for itch relief, though their exact mechanisms of action remain unclear. Research suggests that aluminum acetate may help alleviate pruritus through its astringent properties, which reduce skin irritation and inflammation.46,47 While the precise pathways remain uncertain, clinical studies have demonstrated its effectiveness in managing itch.47 Strontium has demonstrated strong antipruritic effects in non-histaminergic models like cowhage-induced itch, suggesting that it may work through pathways beyond histamine signaling.46 Despite these agents’ growing popularity, further research is needed to understand their specific mechanisms of action fully.

Witch hazel, another widely used ingredient in OTC itch relief formulations, is believed to exert antipruritic effects through its astringent, anti-inflammatory, and antioxidant properties.48 However, further research is needed to determine its effectiveness in reducing pruritus and to clarify the specific pathways through which it alleviates itch. These formulations and their proposed mechanisms of action are summarized in Table 7.

322244 Select OTC preparations with unknown mechanisms.

Generic Name Example Brand Name(s) Mechanism of Action
Aluminum acetate Domeboro®, generic formulations Acts as an astringent, reducing skin irritation and inflammation, but precise antipruritic pathways remain unclear.
Strontium-based formulations TriCalm®, Dermeleve®, generic formulations Proposed anti-itch effects, but specific biological mechanisms have not been well defined.
Witch hazel T.N. Dickinson’s® Witch Hazel Thought to exert antipruritic effects through astringent, anti-inflammatory, and antioxidant properties.

Practical Guidance for Patients

In addition to getting a firm diagnosis and treatment for what drives the itch, managing pruritus often requires proper skin care, lifestyle adjustments, and strategic OTC treatments. A proactive approach to skin care, including regular hydration and protection, is essential to minimizing itch and preventing flare-ups. Maintaining skin hydration through regular use of emollients helps restore the skin barrier and prevents moisture loss that can be associated with itch.49 Applying fragrance-free, hypoallergenic moisturizers immediately after bathing can significantly reduce itching and improve overall skin health.50

Identifying and avoiding potential triggers is another key component of itch management. Common triggers include harsh soaps, fragrances, allergens, dry environments, and excessive heat, all of which can exacerbate symptoms. Patients with chronic or recurrent itch should note any external factors that may worsen their condition and modify their routine accordingly.

OTC treatments can provide significant relief when used appropriately. Topical corticosteroids, such as OTC hydrocortisone, can help reduce inflammation-driven itch but should only be used for short-term symptom relief due to the risk of skin thinning and other side effects with prolonged use.5 Antihistamines, both oral and topical, are another common option. Due to their sedating effects, first-generation oral antihistamines like diphenhydramine can be helpful, particularly for nocturnal itch.7 However, they should be used cautiously, especially in older adults or those operating heavy machinery. Second-generation antihistamines offer longer-lasting relief with less sedation, making them more useful for day-to-day treatment.13 Cooling agents like menthol and camphor and topical anesthetics such as lidocaine or pramoxine can also help alleviate itch through their counter-irritant effects.13,23

Natural remedies, moisturizers, emollients, and skin protectants can provide alternative relief for patients seeking non-pharmacologic options. Some treatments reduce irritation and form a physical barrier, shielding compromised skin from further stressors.30,45 Others can increase water content in the skin, preventing transepidermal water loss and helping soften and smooth the skin, restoring flexibility and comfort, particularly in dry or sensitive skin types.43,44

Patients should know that product formulation and delivery matter when choosing OTC itch treatments. A recent head-to-head study comparing a pramoxine hydrochloride-containing moisturizing cream with a colloidal oatmeal-based itch relief gel found that the gel provided a faster onset of relief and greater itch reduction at 8 hours.51 This study demonstrates the importance of differences in ingredients, texture, and even the application method, which can impact how quickly relief is felt and how satisfied patients are with the product. While this study showed greater efficacy for one product, patients should ultimately let their own experience guide decision-making. Individual responses can vary, and different active compounds and delivery methods may influence how quickly and effectively relief is achieved.

Despite the availability of effective OTC treatments, patients should be educated on when to seek medical attention. If itching persists beyond two weeks without improvement, worsens despite treatment, or is accompanied by additional symptoms such as skin changes, weight loss, or unexplained fever, an underlying systemic condition may be responsible. Patients with chronic dermatologic conditions should consult a healthcare professional to ensure their treatment plan aligns with long-term disease management.

Conflict of Interests Statement

When specific OTC products are mentioned, they are provided as representative examples based on author experience, availability, and market presence at the time of writing. No preference or endorsement is intended.

Disclosures

DM reports no conflicts of interest. PL reports being on the speaker’s bureau for AbbVie, Arcutis, Eli Lilly, Galderma, Hyphens Pharma, Incyte, La Roche-Posay/L’Oréal, Pfizer, Pierre-Fabre Dermatologie, Regeneron/Sanofi Genzyme, Verrica; reports consulting/advisory boards for Alphyn Biologics, AbbVie, Almirall, Amyris, Arcutis, ASLAN, Astria Therapeutics, Boston Skin Science, Bristol-Myers Squibb, Burt’s Bees, Castle Biosciences, Codex Labs, Concerto Biosci, Dermavant, Eli Lilly, Galderma, Kenvue, LEO Pharma, Lipidor, L’Oréal, Merck, Micreos, MyOR Diagnostics, Pelthos Therapeutics, Regeneron/Sanofi Genzyme, Sibel Health, Skinfix, Soteri Skin, Stratum Biosciences, Sun Pharma, Theraplex, Thimble Health, UCB, Unilever, Verdant Scientific, Verrica, Yobee Care. Stock options with Alphyn Labs, Codex Labs, Concerto Biosci, Soteri Skin, Stratum Biosciences, Thimble, Yobee Care, Verdant Scientific. In addition, Dr. Lio has a patent pending for a Theraplex product with royalties paid and is a Board member and Scientific Advisory Committee Member emeritus of the National Eczema Association.

References
1. Kantor R., Dalal P., Cella D., Silverberg J. I.. "Research letter: Impact of pruritus on quality of life-A systematic review." J Am Acad Dermatol, vol. 75, 2016, p. 885. DOI: 10.1016/j.jaad.2016.07.016.
Google Scholar    PubMed Central    PubMed
2. Matterne U., Apfelbacher C. J., Loerbroks A... "Prevalence, correlates and characteristics of chronic pruritus: a population-based cross-sectional study." Acta dermato-venereologica, vol. 91, 2011, p. 674. DOI: 10.2340/00015555-1159.
Google Scholar
3. Shive M., Linos E., Berger T., Wehner M., Chren M. M.. "Itch as a patient-reported symptom in ambulatory care visits in the United States." J Am Acad Dermatol, vol. 69, 2013, p. 550. DOI: 10.1016/j.jaad.2013.05.029.
Google Scholar    PubMed Central    PubMed
4. Chu A. W. L., Rayner D. G., Chu X... "Topical corticosteroids for hives and itch (urticaria): Systematic review and Bayesian meta-analysis of randomized trials." Ann Allergy Asthma Immunol, vol. 133, 2024, p. 437. DOI: 10.1016/j.anai.2024.06.003.
Google Scholar
5. Ellis C. N., Pillitteri J. L., Kyle T. K., Ertischek M. D., Burton S. L., Shiffman S.. "Consumers appropriately self-treat based on labeling for over-the-counter hydrocortisone." J Am Acad Dermatol, vol. 53, 2005, p. 41. DOI: 10.1016/j.jaad.2005.01.107.
Google Scholar
6. Guin J. D.. "Complications of topical hydrocortisone." J Am Acad Dermatol, vol. 4, 1981, p. 417. DOI: 10.1016/S0190-9622(81)70040-9.
Google Scholar
7. Thurmond R. L., Kazerouni K., Chaplan S. R., Greenspan A. J.. "Antihistamines and itch." Handb Exp Pharmacol, vol. 226, 2015, p. 257. DOI: 10.1007/978-3-662-44605-8_15.
Google Scholar
8. Runge J. W., Martinez J. C., Caravati E. M., Williamson S. G., Hartsell S. C.. "Histamine antagonists in the treatment of acute allergic reactions." Ann Emerg Med, vol. 21, 1992, p. 237. DOI: 10.1016/S0196-0644(05)80881-9.
Google Scholar
10. Reilly J. F., Jr., Weisse M. E.. "Topically induced diphenhydramine toxicity." J Emerg Med, vol. 8, 1990, p. 59. DOI: 10.1016/0736-4679(90)90389-D.
Google Scholar
11. Turner J. W.. "Death of a child from topical diphenhydramine." Am J Forensic Med Pathol, vol. 30, 2009, p. 380. DOI: 10.1097/PAF.0b013e31819df748.
Google Scholar
12. Frazier W., Bhardwaj N.. "Atopic Dermatitis: Diagnosis and Treatment." Am Fam Physician, vol. 101, 2020, p. 590. DOI: .
13. Leslie T. A., Greaves M. W., Yosipovitch G.. "Current topical and systemic therapies for itch." Handb Exp Pharmacol, vol. 226, 2015, p. 337. DOI: 10.1007/978-3-662-44605-8_18.
Google Scholar
14. O'Donoghue M., Tharp M.D.. "Antihistamines and their role as antipruritics: Antihistamines as antipruritics." Dermatol Ther, vol. 18, 2005, p. 333. DOI: 10.1111/j.1529-8019.2005.00034.x.
Google Scholar
15. Kim H. J., Park J. B., Lee J. H., Kim I. H.. "How stress triggers itch: a preliminary study of the mechanism of stress-induced pruritus using fMRI." Int J Dermatol, vol. 55, 2016, p. 434. DOI: 10.1111/ijd.12864.
Google Scholar
16. Klein P. A., Clark R. A.. "An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis." Arch Dermatol, vol. 135, 1999, p. 1522. DOI: .
17. He A., Feldman S. R., Fleischer A. B., Jr.. "An assessment of the use of antihistamines in the management of atopic dermatitis." J Am Acad Dermatol, vol. 79, 2018, p. 92. DOI: 10.1016/j.jaad.2017.12.077.
Google Scholar
18. Lee H. S.. "Recent advances in topical anesthesia." J Dent Anesth Pain Med, vol. 16, 2016, p. 237. DOI: 10.17245/jdapm.2016.16.4.237.
Google Scholar    PubMed Central    PubMed
19. Butler D. C., Berger T., Elmariah S. B... "Chronic Pruritus: A Review." JAMA, vol. , 2024, p. . DOI: 10.1001/jama.2024.4899.
Google Scholar
20. Yosipovitch G., Maibach H. I.. "Effect of topical pramoxine on experimentally induced pruritus in humans." J Am Acad Dermatol, vol. 37, 1997, p. 278. DOI: 10.1016/S0190-9622(97)80143-0.
Google Scholar
21. Sobanko J. F., Miller C. J., Alster T. S.. "Topical anesthetics for dermatologic procedures: a review." Dermatol Surg, vol. 38, 2012, p. 709. DOI: 10.1111/j.1524-4725.2011.02271.x.
Google Scholar
22. Hahn I. H., Hoffman R. S., Nelson L. S.. "EMLA-induced methemoglobinemia and systemic topical anesthetic toxicity." J Emerg Med, vol. 26, 2004, p. 85. DOI: 10.1016/j.jemermed.2003.03.003.
Google Scholar
23. Malcolm L.. "Menthoderm®: Helping to manage that itch." Dermatol Nurs (Lond), vol. , 2018, p. . DOI: .
24. Patel T., Ishiuji Y., Yosipovitch G.. "Menthol: a refreshing look at this ancient compound." J Am Acad Dermatol, vol. 57, 2007, p. 873. DOI: 10.1016/j.jaad.2007.04.008.
Google Scholar
25. Yosipovitch G., Bernhard J. D.. "Clinical practice. Chronic pruritus." N Engl J Med, vol. 368, 2013, p. 1625. DOI: 10.1056/NEJMcp1208814.
Google Scholar
26. Weisshaar E., Szepietowski J. C., Darsow U... "European guideline on chronic pruritus in cooperation with the European Dermatology Forum (EDF) and the European Academy of Dermatology and Venereology (EADV)." Acta dermato-venereologica, vol. 92, 2012, p. 563. DOI: 10.2340/00015555-1400.
Google Scholar
27. Hamidpour R., Hamidpour S., Hamidpour M., Shahlari M.. "Camphor (Cinnamomum camphora), a traditional remedy with the history of treating several diseases." Int J Case Rep Images, vol. 4, 2013, p. 86. DOI: 10.5348/ijcri-2013-02-267-RA-1.
Google Scholar
28. Manoguerra A. S., Erdman A. R., Wax P. M... "Camphor Poisoning: an evidence-based practice guideline for out-of-hospital management." Clin Toxicol (Phila), vol. 44, 2006, p. 357. DOI: 10.1080/15563650600671696.
Google Scholar
29. Palkar R., Ongun S., Catich E... "Cooling relief of acute and chronic itch requires TRPM8 channels and neurons." J Invest Dermatol, vol. 138, 2018, p. 1391. DOI: 10.1016/j.jid.2017.12.025.
Google Scholar    PubMed Central    PubMed
30. Parvizi M. M., Salami M. H., Moini Jazani A., Javaheri R., Jaladat A. M., Handjani F.. "Complementary and integrative remedies in the treatment of chronic pruritus: A review of clinical trials." J Cosmet Dermatol, vol. 21, 2022, p. 5360. DOI: 10.1111/jocd.15094.
Google Scholar
31. Fowler E., Yosipovitch G.. "Chronic itch management: therapies beyond those targeting the immune system." Ann Allergy Asthma Immunol, vol. 123, 2019, p. 158. DOI: 10.1016/j.anai.2019.01.016.
Google Scholar
32. Nakhaee S., Nasiri A., Waghei Y., Morshedi J.. "Comparison of Avena sativa, vinegar, and hydroxyzine for uremic pruritus of hemodialysis patients: a crossover randomized clinical trial." Iran J Kidney Dis, vol. 9, 2015, p. 316. DOI: .
33. Gonçalves S., Fernandes L., Caramelo A., Martins M., Rodrigues T., Matos R. S.. "Soothing the itch: The role of medicinal plants in alleviating pruritus in palliative care." Plants, vol. 13, 2024, p. 3515. DOI: 10.3390/plants13243515.
Google Scholar    PubMed Central    PubMed
34. Bai Y., Niu Y., Qin S., Ma G.. "A New Biomaterial Derived from Aloe vera—Acemannan from Basic Studies to Clinical Application." Pharmaceutics, vol. 15, 2023, p. 1913. DOI: 10.3390/pharmaceutics15071913.
Google Scholar    PubMed Central    PubMed
35. West D. P., Zhu Y. F.. "Evaluation of aloe vera gel gloves in the treatment of dry skin associated with occupational exposure." Am J Infect Control, vol. 31, 2003, p. 40. DOI: 10.1067/mic.2003.12.
Google Scholar
36. Heggie S., Bryant G. P., Tripcony L... "A Phase III study on the efficacy of topical aloe vera gel on irradiated breast tissue." Cancer Nurs, vol. 25, 2002, p. 442. DOI: 10.1097/00002820-200212000-00007.
Google Scholar
37. Ferreira M., Teixeira M., Silva E., Selores M.. "Allergic contact dermatitis to Aloe vera." Contact Dermatitis, vol. 57, 2007, p. 278. DOI: 10.1111/j.1600-0536.2007.01118.x.
Google Scholar
38. Szolcsányi J.. "Forty years in capsaicin research for sensory pharmacology and physiology." Neuropeptides, vol. 38, 2004, p. 377. DOI: 10.1016/j.npep.2004.07.005.
Google Scholar
39. Papoiu A. D. P., Yosipovitch G.. "Topical capsaicin. The fire of a "hot" medicine is reignited." Expert Opin Pharmacother, vol. 11, 2010, p. 1359. DOI: 10.1517/14656566.2010.481670.
Google Scholar
40. Carson C. F., Hammer K. A., Riley T. V.. "Melaleuca alternifolia (Tea Tree) oil: a review of antimicrobial and other medicinal properties." Clin Microbiol Rev, vol. 19, 2006, p. 50. DOI: 10.1128/CMR.19.1.50-62.2006.
Google Scholar    PubMed Central    PubMed
41. Storan E. R., Nolan U., Kirby B.. "Allergic contact dermatitis caused by the tea tree oil-containing hydrogel Burnshield®: ALLERGIC CONTACT DERMATITIS CAUSED BY THE HYDROGEL BURNSHIELD®." Contact Dermatitis, vol. 74, 2016, p. 309. DOI: 10.1111/cod.12531.
Google Scholar
42. Della Loggia R., Tubaro A., Sosa S., Becker H., Saar S., Isaac O.. "The role of triterpenoids in the topical anti-inflammatory activity of Calendula officinalis flowers." Planta Med, vol. 60, 1994, p. 516. DOI: 10.1055/s-2006-959562.
Google Scholar
43. Maden S.. "Current approach to moisturizer and emollient utilization in atopic dermatitis: a review." Exploration of Asthma & Allergy, vol. , 2024, p. . DOI: 10.37349/eaa.2024.00056.
Google Scholar
44. Barnes T. M., Mijaljica D., Townley J. P., Spada F., Harrison I. P.. "Vehicles for drug delivery and cosmetic moisturizers: Review and comparison." Pharmaceutics, vol. 13, 2021, p. . DOI: 10.3390/pharmaceutics13122012.
Google Scholar
45. Hoggarth A., Waring M., Alexander J., Greenwood A., Callaghan T.. "A controlled, three-part trial to investigate the barrier function and skin hydration properties of six skin protectants." Ostomy Wound Manage, vol. 51, 2005, p. 30. DOI: .
46. Papoiu A. D. P., Valdes-Rodriguez R., Nattkemper L. A., Chan Y. H., Hahn G. S., Yosipovitch G.. "A novel topical formulation containing strontium chloride significantly reduces the intensity and duration of cowhage-induced itch." Acta Derm Venereol, vol. 93, 2013, p. 520. DOI: 10.2340/00015555-1564.
Google Scholar
47. Papoiu A. D., Chaudhry H., Hayes E. C., Chan Y. H., Herbst K. D.. "TriCalm(®) hydrogel is significantly superior to 2% diphenhydramine and 1% hydrocortisone in reducing the peak intensity, duration, and overall magnitude of cowhage-induced itch." Clin Cosmet Investig Dermatol, vol. 8, 2015, p. 223. DOI: 10.2147/CCID.S78809.
Google Scholar    PubMed Central    PubMed
48. Liu X., Hage T. W., Chen L. C... "Revealing the therapeutic potential: Investigating the impact of a novel Witch Hazel formula on anti-inflammation and antioxidation." J Cosmet Dermatol, vol. 24, 2025, p. e16662. DOI: 10.1111/jocd.16662.
Google Scholar    PubMed Central    PubMed
49. Purnamawati S., Indrastuti N., Danarti R., Saefudin T.. "The role of moisturizers in addressing various kinds of dermatitis: A review." Clin Med Res, vol. 15, 2017, p. 75. DOI: 10.3121/cmr.2017.1363.
Google Scholar    PubMed Central    PubMed
50. Kang S. Y., Um J. Y., Chung B. Y... "Moisturizer in patients with inflammatory skin diseases." Medicina (Kaunas), vol. 58, 2022, p. 888. DOI: 10.3390/medicina58070888.
Google Scholar    PubMed Central    PubMed
51. Hawash A., Nguyen T., Mantilla A., Emesiani C., Meckfessel M.. "Individual article: Evaluation of efficacy and tolerability of two over-the-counter eczema itch relief products." J Drugs Dermatol, vol. 22, 2023, p. SF388641s10. DOI: 10.36849/JDD.8641.
Google Scholar
0
Downloads
0
Total Views
Article impact
Share
Cite
Article Info
DOI:
10.64550/0sjtt120
Reviewed by:
Apple Bodemer, MD, Jacquelyn Dosal, MD
View PDF
Citation
Cite as
[1]
“Beyond the Prescription Pad: A Guide to Over-the-Counter Itch Management: Itch affects millions, disrupting sleep and quality of life; this review explores practical, evidence-based over-the-counter strategies patients can use to safely and effectively manage pruritus”., JOID, vol. 1, no. 1, Jan. 2026, doi: 10.64550/0sjtt120.
Export citation
Select the format you want to export the citation of this publication.
Download Citation
Export Citation